The Journal of Molecular Diagnostics
Volume 14, Issue 2 , Pages 140-148 , March 2012

Impact of Collection and Storage of Lung Tumor Tissue on Whole Genome Expression Profiling

  • Maxim B. Freidin

      Affiliations

    • National Heart and Lung Institute, Imperial College London, London, United Kingdom
    • ,
  • Neesa Bhudia

      Affiliations

    • National Heart and Lung Institute, Imperial College London, London, United Kingdom
    • ,
  • Eric Lim

      Affiliations

    • National Heart and Lung Institute, Imperial College London, London, United Kingdom
    • Department of Thoracic Surgery, Royal Brompton Hospital, London, United Kingdom
    • ,
  • Andrew G. Nicholson

      Affiliations

    • National Heart and Lung Institute, Imperial College London, London, United Kingdom
    • Department of Histopathology, Royal Brompton Hospital, London, United Kingdom
    • ,
  • William O. Cookson

      Affiliations

    • National Heart and Lung Institute, Imperial College London, London, United Kingdom
    • ,
  • Miriam F. Moffatt

      Affiliations

    • National Heart and Lung Institute, Imperial College London, London, United Kingdom
    • Corresponding Author InformationAddress reprint requests to: Miriam F. Moffatt, Ph.D., National Heart and Lung Institute, Imperial College London, Guy Scadding Building, Dovehouse Street, SW6 3LY, London, UK

,Accepted 29 November 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by grants from the Asmarley Trust and the Wellcome Trust (W.O.C. and M.F.M.) and the Royal Brompton and Harefield NHS Foundation Trust (A.G.N. and E.L.).

 E.L. serves as a paid consultant for Stratagene, Abbott Molecular, and GlaxoSmithKline; holds patents together with ClearBridge BioMedics; has received payment for development of educational presentations from Roche and Imedex; and has received travel-related expense reimbursement from Covidien.

 Supplemental material for this article can be found at http://jmd.amjpathol.org or at doi: 10.1016/j.jmoldx.2011.11.002.

PII: S1525-1578(11)00316-3

doi: 10.1016/j.jmoldx.2011.11.002

The Journal of Molecular Diagnostics
Volume 14, Issue 2 , Pages 140-148 , March 2012

Article Tools

* Image Usage & Resolution